BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

143 related articles for article (PubMed ID: 1255764)

  • 21. Comparison of T-antigen expression in normal, premalignant, and malignant human colonic tissue using lectin and antibody immunohistochemistry.
    Yuan M; Itzkowitz SH; Boland CR; Kim YD; Tomita JT; Palekar A; Bennington JL; Trump BF; Kim YS
    Cancer Res; 1986 Sep; 46(9):4841-7. PubMed ID: 3731131
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Comparative immunoperoxidase demonstration of T-antigens in human colorectal carcinomas and morphologically abnormal mucosa.
    Orntoft TF; Mors NP; Eriksen G; Jacobsen NO; Poulsen HS
    Cancer Res; 1985 Jan; 45(1):447-52. PubMed ID: 3880667
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Association of antigen expression and DNA ploidy in human colorectal tumors.
    Durrant LG; Robins RA; Armitage NC; Brown A; Baldwin RW; Hardcastle JD
    Cancer Res; 1986 Jul; 46(7):3543-9. PubMed ID: 3518917
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Distribution of monoclonal antibody-defined monosialoganglioside in normal and cancerous human tissues: an immunoperoxidase study.
    Arends JW; Verstynen C; Bosman FT; Hilgers J; Steplewski Z
    Hybridoma; 1983; 2(2):219-29. PubMed ID: 6381289
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Detection of T-antigen in colorectal adenocarcinoma and polyps].
    Xu S; Lu Y; Wang Q
    Zhonghua Nei Ke Za Zhi; 1995 Oct; 34(10):693-5. PubMed ID: 8731834
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Specific antigen in serum of patients with colon carcinoma.
    Koprowski H; Herlyn M; Steplewski Z; Sears HF
    Science; 1981 Apr; 212(4490):53-5. PubMed ID: 6163212
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Immunohistochemical studies of blood group substance H in colorectal tumors using a monoclonal antibody.
    Compton C; Wyatt R; Konugres A; Ehrenthal D; Durda P
    Cancer; 1987 Jan; 59(1):118-27. PubMed ID: 2431754
    [TBL] [Abstract][Full Text] [Related]  

  • 28. A method for T-antigen demonstration by a polyclonal antibody and peanut lectin; elimination of cross-reaction with naturally occurring antibodies.
    Orntoft TF
    Virchows Arch A Pathol Anat Histopathol; 1984; 404(2):159-66. PubMed ID: 6435306
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Immunospecificity of nuclear nonhistone protein-DNA complexes in colon adenocarcinoma.
    Chiu JF; Decha-Umphal W; Markert C; Little BW
    J Natl Cancer Inst; 1979 Aug; 63(2):313-7. PubMed ID: 88536
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Lewisx- and sialylated Lewisx-related antigen expression in human malignant and nonmalignant colonic tissues.
    Itzkowitz SH; Yuan M; Fukushi Y; Palekar A; Phelps PC; Shamsuddin AM; Trump BF; Hakomori S; Kim YS
    Cancer Res; 1986 May; 46(5):2627-32. PubMed ID: 3516383
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Blood group substances (BG) as carcinofetal antigens in carcinomas of the distal colon.
    Denk H; Tappeiner G; Holzner JH
    Eur J Cancer (1965); 1974 Aug; 10(8):487-90. PubMed ID: 4463000
    [No Abstract]   [Full Text] [Related]  

  • 32. Newer concepts of cancer of the colon and rectum: clinical evaluation of a radioimmunoassay for CEA.
    LeBel JS; Deodhar SD; Brown CH
    Dis Colon Rectum; 1972; 15(2):111-5. PubMed ID: 5026787
    [No Abstract]   [Full Text] [Related]  

  • 33. Monoclonal antibodies to human colon and colorectal carcinoma.
    Thompson CH; Jones SL; Pihl E; McKenzie IF
    Br J Cancer; 1983 May; 47(5):595-605. PubMed ID: 6342646
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Monoclonal antibodies against gastrointestinal tumour-associated antigens isolated as monosialogangliosides.
    Lindholm L; Holmgren J; Svennerholm L; Fredman P; Nilsson O; Persson B; Myrvold H; LagergÄrd T
    Int Arch Allergy Appl Immunol; 1983; 71(2):178-81. PubMed ID: 6840874
    [TBL] [Abstract][Full Text] [Related]  

  • 35. HLA antigens in colorectal tumours--low expression of HLA class I antigens in mucinous colorectal carcinomas.
    van den Ingh HF; Ruiter DJ; Griffioen G; van Muijen GN; Ferrone S
    Br J Cancer; 1987 Feb; 55(2):125-30. PubMed ID: 3028461
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Elevated levels of p53 antigen in cultured skin fibroblasts from patients with hereditary adenocarcinoma of the colon and rectum and its relevance to oncogenic mechanisms.
    Kopelovich L; DeLeo AB
    J Natl Cancer Inst; 1986 Dec; 77(6):1241-6. PubMed ID: 3467115
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Monoclonal antibodies to human colorectal tumor-associated antigens: improved elicitation and subclass restriction.
    Morgan AC; Woodhouse CS; Knost JA; Abrams PG; Clarke GC; Arthur LO; McIntyre R; Ochs JJ; Foon KA; Oldham RK
    Hybridoma; 1984; 3(3):233-45. PubMed ID: 6500584
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Cell-mediated immunity in adenocarcinoma of the colo-rectum.
    Greco RS; Salvati E; Rubin R; Shaikh KA
    J Surg Res; 1978 Apr; 24(4):253-8. PubMed ID: 347172
    [No Abstract]   [Full Text] [Related]  

  • 39. Generation of tumor cell-reactive human monoclonal antibodies using peripheral blood lymphocytes from actively immunized colorectal carcinoma patients.
    Haspel MV; McCabe RP; Pomato N; Janesch NJ; Knowlton JV; Peters LC; Hoover HC; Hanna MG
    Cancer Res; 1985 Aug; 45(8):3951-61. PubMed ID: 4016762
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Chemical and immunological differences between normal and tumoral colonic mucoprotein antigen.
    Gold D; Miller F
    Nature; 1975 May; 255(5503):85-7. PubMed ID: 805373
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.